secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K/A
Filed at:   2026-07-09T20:05:15+00:00
Accession:  0001493152-26-032680
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 3.02, 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

DNA X raises $2.5M in Series B Preferred, cancels $3.1M debt to meet Nasdaq equity requirement
--------------------------------------------------------------------------------

- Sold 929,864 Series B Preferred shares for $2.5M cash and cancellation of $3.1M convertible note balance.
- Pro forma stockholders' equity as of July 9, 2026 is $3.798M, above Nasdaq's $2.5M minimum.
- Remaining 416,667 Series B shares expected to close by August 14, 2026.
- Company awaits Nasdaq formal determination of compliance with minimum equity rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226032680/0001493152-26-032680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226032680/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-032680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer